[PHARMA] YoY Annualized Quarter Result on 30-Sep-2019 [#3]

Announcement Date
20-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- -32.22%
YoY- -22.75%
Quarter Report
View:
Show?
Annualized Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 3,530,609 5,471,062 2,787,317 2,806,462 2,384,416 2,281,018 2,141,608 8.68%
PBT 76,732 202,649 65,732 62,145 77,706 70,930 90,597 -2.72%
Tax -24,536 -86,596 -21,310 -23,097 -26,160 -27,065 -28,252 -2.32%
NP 52,196 116,053 44,421 39,048 51,546 43,865 62,345 -2.91%
-
NP to SH 49,430 115,566 45,093 39,172 50,708 42,697 61,913 -3.68%
-
Tax Rate 31.98% 42.73% 32.42% 37.17% 33.67% 38.16% 31.18% -
Total Cost 3,478,413 5,355,009 2,742,896 2,767,414 2,332,869 2,237,153 2,079,262 8.95%
-
Net Worth 411,327 391,428 345,040 516,387 522,618 531,892 530,907 -4.16%
Dividend
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Div 33,185 75,056 34,852 29,557 48,535 44,973 44,889 -4.90%
Div Payout % 67.14% 64.95% 77.29% 75.46% 95.71% 105.33% 72.50% -
Equity
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Net Worth 411,327 391,428 345,040 516,387 522,618 531,892 530,907 -4.16%
NOSH 1,309,126 1,309,126 261,705 261,229 260,505 259,821 258,979 30.98%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 1.48% 2.12% 1.59% 1.39% 2.16% 1.92% 2.91% -
ROE 12.02% 29.52% 13.07% 7.59% 9.70% 8.03% 11.66% -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
RPS 269.52 417.92 1,066.33 1,076.09 917.05 879.14 826.94 -17.03%
EPS 3.77 8.83 17.25 15.01 19.51 16.45 23.91 -26.48%
DPS 2.53 5.73 13.33 11.33 18.67 17.33 17.33 -27.42%
NAPS 0.314 0.299 1.32 1.98 2.01 2.05 2.05 -26.84%
Adjusted Per Share Value based on latest NOSH - 261,229
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
RPS 244.97 379.60 193.40 194.72 165.44 158.27 148.59 8.68%
EPS 3.43 8.02 3.13 2.72 3.52 2.96 4.30 -3.69%
DPS 2.30 5.21 2.42 2.05 3.37 3.12 3.11 -4.90%
NAPS 0.2854 0.2716 0.2394 0.3583 0.3626 0.369 0.3684 -4.16%
Price Multiplier on Financial Quarter End Date
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Date 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 -
Price 0.515 0.835 4.32 2.44 2.89 4.14 5.58 -
P/RPS 0.19 0.20 0.41 0.23 0.32 0.47 0.67 -18.93%
P/EPS 13.65 9.46 25.04 16.25 14.82 25.16 23.34 -8.54%
EY 7.33 10.57 3.99 6.16 6.75 3.97 4.28 9.37%
DY 4.92 6.87 3.09 4.64 6.46 4.19 3.11 7.94%
P/NAPS 1.64 2.79 3.27 1.23 1.44 2.02 2.72 -8.08%
Price Multiplier on Announcement Date
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Date 24/11/22 19/11/21 19/11/20 20/11/19 19/11/18 15/11/17 21/11/16 -
Price 0.55 0.845 5.72 2.21 3.09 3.82 5.70 -
P/RPS 0.20 0.20 0.54 0.21 0.34 0.43 0.69 -18.64%
P/EPS 14.58 9.57 33.16 14.71 15.84 23.21 23.84 -7.86%
EY 6.86 10.45 3.02 6.80 6.31 4.31 4.19 8.55%
DY 4.61 6.79 2.33 5.13 6.04 4.54 3.04 7.18%
P/NAPS 1.75 2.83 4.33 1.12 1.54 1.86 2.78 -7.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment